维普期刊资源整合服务平台（V6.5）

135篇 您的检索式：作者名="Schermuly"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Reversal of experimental pulmonary hypertension by PDGF inhibition显示文摘	Schermuly R T Dony E Ghofrani H A	2005	J Clin Invest2005，115，10：	1
2	Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats显示文摘	Schermuly RT Kreisselmeier KP Ghofrani HA	2004	Am J Respir Crit Care Med2004，169，1：	1
3	Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats显示文摘	Schermuly RT Kreisselmeier KP Ghofrani HA	2004	Am J Respir Crit Care Med2004，169，1：	1
4	Differential inpact of ul- trasonically nebulized versus tracheal-instilled surfactant on ventila- tion (VMQ) mismatch in a model of acute lung injnry显示文摘	Schermuly RT Gunther A Weiss MN	2000	Am J Respir Crit Care Med2000，161，1：	1
5	Regulation of hypoxic pulmonary vasoconstriction: basic mechanisms 显示文摘	Sommer N Dietrich A Schermuly RT	2008	Eur Respir J2008，32，6：	1
6	Riociguat for the treatment of pulmonary hypertension显示文摘	Ralph T Schermuly Wiebke Janssen Norbert Weissmann Johannes-Peter Stasch Friedrich Grimminger Hossein Ardeschir Ghofrani	2011	Expert Opinion on Investigational Drugs2011，，4：	1
7	Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats显示文摘	Schermuly RT Kreisselmeier KP Ghofrani HA	2004	Am J Respir Crit Care Med2004，169，1：	1
8	PDGF receptor and its antagonistas:role in treatment of PAH显示文摘	Grimminger F Schermuly RT	2010	Adv Exp Med Biol2010，661，10：	1
9	Regulation of hypoxic pulmonary vasoconstriction:basic mechanisms显示文摘	SOMMER N DIETRICH A SCHERMULY R T	2008	Eur Respir J2008，32，6：	1
10	Fhl-1, a New Key Protein in Pulmonary Hypertension显示文摘	Grazyna Kwapiszewska Malgorzata Wygrecka Leigh M. Marsh Sigrid Schmitt Roger Tr?sser Jochen Wilhelm Katja Helmus Bastian Eul Anna Zakrzewicz Hossein A. Ghofrani Ralph T. Schermuly Rainer M. Bohle Friedrich Grimminger Werner Seeger Oliver Eickelberg Ludger	2008	Circulation2008，，11：	1
11	NADPH Oxidases-do they play a role in TRPC regulation under hypoxia?显示文摘	Malczyk M Veith C Schermuly RT	2016	Pflugers Arch :Eur J Physiol2016，468，1：	1
12	Pharma- cokinetics and metabolism of infused versus inhaled ilo- prost in isolated rabbit lungs 显示文摘	Schermuly R T Schulz A Ghofrani H A	2002	J Pharmacol Exp Ther2002，303，2：	1
13	The science of endo thelin 1 and endothelin receptor antagonists in the management of pul- monary arterial hypertension: current understanding and future stud- ies 显示文摘	Davie N J Schermuly RT Weissmann N	2009	Eur J Clin Invest2009，39，2：	1
14	Reversal of experimental pulmonary hypertension by PDGF inhibition显示文摘	SCHERMULY R T DONY E GHOFRANI H A	2005	J Clin Invest2005，115，：	1
15	Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension 显示文摘	Ghofrani HA Rose F Schermuly RT	2003	J Am Coll Cardiol2003，42，1：	1
16	Riociguat for the treatment of pulmonary hypertension 显示文摘	Schermuly RT Janssen W Weissmann N	2011	Expert Opin Investig Drugs2011，20，4：	1
17	Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension显示文摘	Schermuly RT Kreisselmeier KP Ghofrani HA	2004	Circul Res2004，94，8：	1
18	Glycogen syn thase kinase 3 beta contributes to proliferation of arterial smooth muscle cells inpulmonary hypertension显示文摘	Sklepkiewicz P Schermuly R T Tian X etal	2011	PLoS One2011，8，18：	1
19	Riociguat for the treatment of pulmonary hypertension显示文摘	Schermuly RT Janssen W Weissmann N	2011	Expert Opin Investig Drugs2011，20，4：	1
20	Oral sildenfil as longterm adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension显示文摘	Ghofrani H A Rose F Schermuly R T	2003	J Am Coll Cardiol2003，42，：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示